B2B only. For licensed importers and distributors. Tender authorities and healthcare institutions are also served. Not for retail or patient supply.  ·  Compliance statement
Home/Insights/Philippines
Philippines

How to import blood products into the Philippines

Importing a plasma-derived product or vaccine into the Philippines runs through the Food and Drug Administration (FDA). The shape is familiar — register the product locally, with the right dossier, through a local licence holder — but the details are specific to the Philippines.

For a Chinese plasma product, import into the Philippines is two questions. First, whether China will export it — covered in the export regulations and market-entry guide. Second, whether the Philippines will register and admit it. This page is about the second question.

The regulator and the law

The Food and Drug Administration (FDA) of the Philippines regulates medicines, vaccines and biologicals under Republic Act No. 3720 (as amended) and Republic Act No. 9711. Biological products — including vaccines, blood products and plasma-derived medicinal products — are handled through the FDA's Center for Drug Regulation and Research (CDRR) and require additional quality and comparability data over and above a standard chemical drug.

The authorisations you need

Three documents sit at the centre of a Philippine import, and they are often confused. They are separate, and all three matter:

AuthorisationWhat it isWho holds it
Certificate of Product Registration (CPR)The FDA's authorisation for a specific product to be marketed and importedThe Philippine Marketing Authorisation Holder
License to Operate (LTO)Licence to operate an establishment (importer/distributor)The Philippine-registered entity
FDA Import PermitPermit for each shipment of an overseas-manufactured productThe licensed importer

The key constraint: the Marketing Authorisation Holder must be a Philippine-registered entity. A Chinese exporter cannot hold the Philippine registration. What the exporter contributes is the product file, and what the local holder contributes is the licence and the filing.

The dossier format

The Philippine FDA requires the ASEAN Common Technical Document (ACTD) format — the standard for the ASEAN region. The core file a Chinese exporter must supply is the same one described in the general market-entry guide:

For biologicals, the FDA also requires quality and comparability data beyond a conventional drug — a point to plan for before the dossier is assembled, not discovered at screening.

The sequence, end to end

StepWhat happensWho does it
1. Confirm exportabilityProduct is finished, registered, batch-released — not source plasmaExporter + manufacturer
2. Confirm importabilityThe Philippines admits this product class and there is a viable CPR pathLocal holder + FDA
3. Assemble the ACTD dossierCPP, approval number, batch release, GMP, CoA, export mandateExporter provides; local holder adapts
4. File for the CPRSubmit through the FDA, through the Philippine MAHLocal MAH
5. Import & releaseShip with an FDA import permit, then release the batch for useLicensed importer + FDA

The Certificate of Product Registration is valid for five years and must be renewed at least 90 days before expiry. Post-approval changes — formulation, packaging or site — go through a variation application.

How a Chinese export agent fits in

Wanyoda's role is the export side of this sequence. We hold the written export mandates from NMPA-licensed manufacturers and coordinate the product file — approval number verification, CPP, batch release and GMP evidence — so the Philippine holder receives a complete, filing-ready dossier. We do not hold the Philippine registration, because by law it cannot be held by a foreign company; the appointed distributor is the licence holder.

What this means in practice: the fastest Philippine entry is one where the export-side product file is already complete and the local holder already has its LTO. Registration then becomes adaptation and filing rather than a long evidence-gathering exercise.

The Philippine constraint that matters most: the CPR is held locally. Choose an export partner whose product file is complete on day one, and the local filing is the only remaining variable.

Where Wanyoda already has Philippine records

Two products carry Philippine regulatory records that shorten this path. Rabies immunoglobulin holds Philippine GMP certification (2026), and Boya IVIG holds a Philippine GMP waiver. Human albumin and rabies vaccines are open territories where registration is initiated jointly with the appointed distributor. See the full picture on the Philippines market page.

Frequently asked questions

What authorisation is required to import a blood product into the Philippines?

The product must hold a Certificate of Product Registration (CPR) from the FDA of the Philippines, held by a Philippine-registered Marketing Authorisation Holder. The importing establishment also needs a License to Operate (LTO) and, for overseas-manufactured products, an FDA import permit.

What dossier format does the Philippine FDA require?

The Philippine FDA requires the ASEAN Common Technical Document (ACTD) format, supported by GMP evidence, a Certificate of Pharmaceutical Product, and compliant labelling. Biological products need additional quality and comparability data.

Can a foreign company hold the Philippine registration?

No. The Marketing Authorisation Holder must be a Philippine-registered entity with a valid License to Operate. The Chinese exporter supplies the product file, and the local holder adapts and files the dossier.

How long is a Certificate of Product Registration valid?

A Certificate of Product Registration in the Philippines is valid for five years and must be renewed at least 90 days before expiry.

Where to go next

Philippines

Map your Philippine entry.

Tell us the product and your licence position, and we will lay out the FDA registration path — what your market needs, and what we can hand over on day one.